U.S. Insurance Stock News

Over the last 7 days, the United States market has experienced a 2.7% drop, though it has risen by 23% over the past year, with earnings forecasted to grow by 17% annually. In this fluctuating environment, identifying undervalued stocks can present opportunities for investors seeking to capitalize on potential growth and favorable market estimates.

Over the last 7 days, the United States market has dropped 2.7%, yet it has shown resilience with a 23% rise over the past year and expectations for earnings to grow by 17% annually in the coming years. In this context, growth companies with high insider ownership, such as ATRenew and two others we'll explore, can be particularly appealing as they often indicate strong internal confidence in their long-term potential.

Over the last 7 days, the United States market has dropped 2.7%, but it has risen by 23% in the past year, with earnings forecasted to grow by 17% annually. For investors willing to explore beyond well-known stocks, penny stocks—though a somewhat outdated term—still represent an intriguing investment area due to their affordability and potential for growth. This article highlights three penny stocks that stand out for their financial strength and resilience, offering compelling opportunities...

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 23% over the past year with earnings forecasted to grow by 17% annually. In such dynamic conditions, dividend stocks that offer consistent payouts and potential for capital appreciation can be an attractive option for investors seeking stability and income.

Apogee Therapeutics (APGE) stock is in focus after positive 16-week Phase 2 APEX data for zumilokibart in atopic dermatitis, followed by a milestone-based, non-dilutive financing package of up to US$1.3b from Blackstone Life Sciences. See our latest analysis for Apogee Therapeutics. After a sharp rally tied to the Phase 2 APEX data and US$1.3b Blackstone financing, Apogee’s share price has eased 4.5% over the last day, although the 1-year total shareholder return of 106.85% points to strong...

CPS Technologies (CPSH) has filed a follow-on equity offering to raise US$9.6 million by issuing 1,200,000 common shares at US$8 each in a registered direct deal, introducing fresh capital and potential dilution. See our latest analysis for CPS Technologies. The follow on offering comes after a sharp run, with a 30 day share price return of 95.21% and year to date share price return of 142.19%. The 1 year total shareholder return of 181.82% points to strong longer term momentum despite...

Event context and recent stock performance Palvella Therapeutics (PVLA) has drawn fresh attention after recent trading saw the stock close at US$105.25. This move comes alongside a year-to-date gain of 5% and a 1-year total return near 3x. See our latest analysis for Palvella Therapeutics. Recent trading has been choppy, with the share price down 3.15% on the day, 6.52% over the past week and 25.94% over the past quarter. At the same time, the 1 year total shareholder return sits near 3x,...

Some Natera, Inc. ( NASDAQ:NTRA ) shareholders may be a little concerned to see that the Lead Independent Director...

Victoria's Secret & Co. ( NYSE:VSXY ) just released its latest quarterly results and things are looking bullish. It was...

NGL Energy Partners LP has reported past fourth-quarter 2026 revenue of US$949.51 million and a net loss of US$287.68 million, reversing from profit a year earlier and contributing to a full-year loss on lower annual revenue of US$3.16 billion. Despite this swing into loss, the partnership continued its unit repurchase program through March 2026, retiring about 6.71% of outstanding units for roughly US$49.56 million, which may influence how investors interpret management’s confidence and...

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 23% over the past year with projected annual earnings growth of 17%. In this fluctuating environment, identifying small-cap stocks that are undervalued and exhibit insider activity can present unique opportunities for investors seeking to capitalize on potential market inefficiencies.

Over the last 7 days, the United States market has dropped 2.7%, yet it remains up by 23% over the past year, with earnings forecasted to grow by 17% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that exhibit strong innovation potential and robust financial health to capitalize on future opportunities.

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it has risen by 23% over the past year with earnings expected to grow by 17% annually. In this context, growth stocks with high insider ownership can offer unique insights into potential opportunities as insiders may have confidence in their company's future prospects and are often aligned with shareholder interests.

Over the last 7 days, the U.S. market has dropped by 2.7%, yet it has risen by 23% over the past year, with earnings forecasted to grow annually by 17%. For investors interested in smaller or newer companies, penny stocks — despite being an older term — remain relevant as they can offer surprising value and growth potential when backed by strong financials. This article highlights several penny stocks that stand out for their financial strength, presenting opportunities for those seeking...

We wouldn't blame OneSpaWorld Holdings Limited ( NASDAQ:OSW ) shareholders if they were a little worried about the fact...

Some Krystal Biotech, Inc. ( NASDAQ:KRYS ) shareholders may be a little concerned to see that the Founder, Krish...

Anyone interested in Alector, Inc. ( NASDAQ:ALEC ) should probably be aware that the Co-Founder, Arnon Rosenthal...

Whilst it may not be a huge deal, we thought it was good to see that the Baozun Inc. ( NASDAQ:BZUN ) Co-Founder, Junhua...

By selling US$117k worth of Zentalis Pharmaceuticals, Inc. ( NASDAQ:ZNTL ) stock at an average sell price of US$2.43...

Those following along with Ryan Specialty Holdings, Inc. ( NYSE:RYAN ) will no doubt be intrigued by the recent...

OpenAI’s confidential plan to go public at a potential valuation above $1t is not just a headline; it is a possible reset moment for how markets think about fast growing AI platforms and the companies around them. If investor appetite for this IPO is strong, it could influence pricing, expectations and capital flows across newer listings. This article highlights 3 stocks from our IPO Investment Opportunities screener that are exposed to this news in different ways, helping you decide whether...

Insiders who bought US$450.3k worth of Aardvark Therapeutics, Inc.'s ( NASDAQ:AARD ) stock at an average buy price of...

Citizens Financial Services, Inc. ( NASDAQ:CZFS ) stock is about to trade ex-dividend in 2 days. The ex-dividend date...

In recent months, JBS has faced legal action from Greenpeace in the Netherlands over alleged environmental and human rights failings, while China suspended beef imports from its Vilhena, Brazil plant after detecting a growth hormone. Together, these disputes highlight how regulatory and ethical scrutiny in key export markets can directly challenge JBS’s global expansion plans and operating flexibility. We’ll now examine how the China import suspension, in particular, may reshape JBS’s...